Publication date: Available online 9 March 2017
Source:Endocrinology and Metabolism Clinics of North America
Author(s): Rodrigo Almeida Toledo
Teaser
Genomic studies conducted by different centers have uncovered various new genes mutated in pheochromocytomas and paragangliomas (PPGLs) at germline, mosaic, and/or somatic levels, greatly expanding our knowledge of the genetic events occurring in these tumors. The current review focuses on very newly findings and discusses the previously not recognized role of MERTK, MET, fibroblast growth factor receptor 1, and H3F3A genes in syndromic and nonsyndromic PPGLs. These 4 new genes were selected because, although their association with PPGLs is very recent, mounting evidence was generated that rapidly consolidated the prominence of these genes in the molecular pathogenesis of PPGLs.http://ift.tt/2m1Tise
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου